Pipeline

DIGNA leverages world-class scientific and clinical expertise to turn early-stage medical innovations into clinical-stage partnering candidates for further development and subsequent commercialization.

 

P17 P17
Porphyria Vector CT1 OSM + IFN Interapo MTA IFN alfa 5


Descarga la información del pipeline en formato pdf.